Nordic Pharma

Nordic Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Nordic Pharma is a privately owned, medium-size, fully integrated Pharma company with a history of internal product development and acquisitions. We focus on the development and commercialization of specialty products, which include, but are not limited to, niche hospital and orphan products, to address unmet medical needs. Our expertise relies on the development and sales of our own products, but also on partner products acquired at various stages of development. Today, Nordic Pharma has a range of highly specialized proprietary and in-licensed products in the following therapeutic areas: Rheumatology, Women’s Health and Critical Care (Anaesthesia, Haematology, Oncology). We have established deep roots throughout Europe, and more recently, expanded outside of Europe, with the creation of an affiliate in Canada. Our driving force is about innovative and efficient products to fight diseases. We strive to bring solutions to specific unmet medical needs, contributing to improved patient care. Nordic Pharma’s values of Commitment, Ambition, Respect, Reliability, Integrity and Agility describe our culture and standards and guide us in our way of working.

Company Details

Employees
236
Founded
-
Address
Siriusdreef 41, Hoofddorp,north Holland 2132 Wt,netherlands
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Hoofddorp, North Holland
Looking for a particular Nordic Pharma employee's phone or email?

Nordic Pharma Questions

News

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADE - Yahoo Finance

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADE Yahoo Finance

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension) - PR Newswire

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension) PR Newswire

Nordic Pharma launches authorized generic of Maxitrol - Eyes On Eyecare

Nordic Pharma launches authorized generic of Maxitrol Eyes On Eyecare

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCI - PR Newswire

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCI PR Newswire

Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch - Pharmafile

Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch Pharmafile

Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch - Medical Independent

Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch Medical Independent

Amring Pharmaceuticals changes name to Nordic Pharma - Healio

Amring Pharmaceuticals changes name to Nordic Pharma Healio

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LACRIFILL® CANALICULAR GEL INCLUSION IN NEW DRY EYE WORKSHOP (DEWS) III MANAGEMENT AND THERAPY REPORT FROM THE TEAR FILM A - PR Newswire

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LACRIFILL® CANALICULAR GEL INCLUSION IN NEW DRY EYE WORKSHOP (DEWS) III MANAGEMENT AND THERAPY REPORT FROM THE TEAR FILM A PR Newswire

Amring Changes Name to Nordic Pharma, Inc. Amid Ownership Change - Pharmaceutical Executive

Amring Changes Name to Nordic Pharma, Inc. Amid Ownership Change Pharmaceutical Executive

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Continues Its Introduction of LACRIFILL Canalicular Gel, a Novel Therapy for Dry Eye, During American Academy of Ophthalmology (AAO) 2024 - Business Wire

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Continues Its Introduction of LACRIFILL Canalicular Gel, a Novel Therapy for Dry Eye, During American Academy of Ophthalmology (AAO) 2024 Business Wire

Nordic Pharma announces commercial launch of Lacrifill canalicular gel - Optometry Times

Nordic Pharma announces commercial launch of Lacrifill canalicular gel Optometry Times

VIDEO: Nordic Pharma Eye Care prepares for Lacrifill launch at ASCRS - Healio

VIDEO: Nordic Pharma Eye Care prepares for Lacrifill launch at ASCRS Healio

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES DETAILS OF LACRIFILL® CANALICULAR GEL POSTER PRESENTATION AT SECO 2025 - PR Newswire

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES DETAILS OF LACRIFILL® CANALICULAR GEL POSTER PRESENTATION AT SECO 2025 PR Newswire

Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership - Business Wire

Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership Business Wire

Nordic Pharma launches Lacrifill Canalicular Gel dry eye therapy in the US - Eyes On Eyecare

Nordic Pharma launches Lacrifill Canalicular Gel dry eye therapy in the US Eyes On Eyecare

Nordic Pharma and Clinigen sign global Trasylol supply deal - Fierce Biotech

Nordic Pharma and Clinigen sign global Trasylol supply deal Fierce Biotech

Nordic Pharma acquires Visant, plans launch of dry eye disease therapy - Healio

Nordic Pharma acquires Visant, plans launch of dry eye disease therapy Healio

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States - Business Wire

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States Business Wire

Nordic Pharma buys Visant Medical with plans for dry eye product launch - Eyes On Eyecare

Nordic Pharma buys Visant Medical with plans for dry eye product launch Eyes On Eyecare

Nordic Pharma Ireland launch Dnord 255mg soft gel capsule - Irish Medical Times

Nordic Pharma Ireland launch Dnord 255mg soft gel capsule Irish Medical Times

Top Nordic Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant